mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.8 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.0064 |
0.8 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |